Select Data competitors

Serial entrepreneur, board member and strategist. Particular knowledge in diagnostics and healthcare services.

I am an aspiring sports broadcaster from Pembroke, Massachusetts. As a dedicated and hard-working leader, success is something I pride myself on. Thus, going above and beyond the bare minimum is something I strive for constantly. From the moment I stepped on campus at Quinnipiac University, I understood how extra curricular activities were the key to success. Therefore, I quickly joined student media organizations and gained extensive knowledge from the start. I now have two years experience in a student-run news room. Editing and shooting video, writing for print and for broadcast, play by play and color commentary, and control room operations are all skills I have gained from my hands on experience outside of the classroom.

John Cruickshank is a CEO:Lovelace Medical Group at Lovelace Health System and Chief Medical Officer at Lovelace Health System.

Wylecia Wiggs Harris is a Chief Executive Officer at American Health Information Management Association (AHIMA) and is based in Chicago, Illinois. She has worked as Executive Director at Sister To Sister Everyone Has A Heart Foundation Inc, Chief Operating Officer at American Nurses Association Inc, and Executive Director at Center for American Nurses. Wylecia works or has worked as Daisy Scout Troop Treasurer at Daisy Scout Troop; Participant at ASAE, Diversity Summit; and Board Member at Sister To Sister Everyone Has A Heart Foundation Inc. She studied at Capella University between 2006 and 2011, Chaordix between 1978 and 1982, and University of Tasmania between 1982 and 1984.

Norma Diaz is a Chief Executive Officer at Community Health Group and is based in Greater San Diego Area.

Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (''ICSL''). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician's Choice Management, LLC (''PCM''), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.

Jake Orville has 20+ years of diagnostic, life science and medical device management experience within both established and emerging markets. As the General Manager of Pipeline at Exact Sciences, Jake leads the company's efforts to develop and advance solutions for earlier detection and life changing answers across the cancer continuum. Prior to Exact Sciences, Jake co-founded Cleveland HeartLab, Inc. (CHL) and served as the CEO from inception to exit. CHL was spun-out of the Cleveland Clinic to develop and rapidly commercialize unique diagnostic technologies, with applications in cardiovascular and inflammatory indications. CHL was acquired by Quest Diagnostics in December 2017. Jake Served as the General Manager of the Cardiometabolic & Endocrinology Franchise at Quest. Under Jake’s leadership, CHL was recognized as Ohio’s Venture of the Year (2012); received an Economic Impact Award by the city of Cleveland for job creation (2013) and was recognized as an Inc. 500 fastest growing private company in the US (2014). Jake has been recognized as a Top 50 Smart Leader by Smart Magazine and received the Annual Innovation Award in 2018 Prior to co-founding Cleveland HeartLab, Jake was CEO of Prognostix and held Senior Management positions with two publically traded companies (NextGen Sciences - AIM NGG.L; Third Wave Technologies - Nasdaq TWTI). He is a co-founder of Viridian Medical and Tolera Therapeutics and currently sits on the Board of Directors for The Wisconsin Women’s Health Foundation. Jake has raised capital from multiple sources, including top tier venture funds, strategic and international investors as well as angels, family offices and state funding sources. A well recognized entrepreneur, he has given many lectures on innovation, commercialization, early stage ventures, technology transfer and intellectual property. Jake received his Bachelor of Arts from the University of Massachusetts, Amherst and his MBA from the University of Wisconsin, Madison.

As the President and Chief Executive Officer of SCL Health, Lydia Jumonville oversees and ensures operational, financial and clinical success across the health system. She is responsible for leading, managing and providing strategic direction for the organization, while also ensuring that patients and SCL Health’s Mission remain at the core of efforts across the 16,000-person system.